Zum Hauptinhalt springen
CAS 0 Einträge

CAS 10103-46-5

CAS 10103-46-5 entspricht 0 EU-Anhangseinträgen in den Anhängen II–VI der Verordnung (EG) Nr. 1223/2009.

Einträge zu CAS 10103-46-5

0 insgesamt
Für diese CAS-Nummer wurden keine Einträge gefunden.

Chemische Identität und Eigenschaften

Chemische 2D-Struktur aus PubChem für CAS 10103-46-5
CAS 10103-46-5PubChem CID 24456

Tricalcium Phosphate

Calcium phosphate is typically available as an over the counter supplement, antacid, or as an added ingredient in some toothpastes. — DrugBank

IUPAC-Name
tricalcium diphosphate
Summenformel
Ca3O8P2
Molekulargewicht
310.18 g/mol
Exakte Masse
309.7946135 Da
Topologische polare Oberfläche
173,0 Ų
Wasserstoffbrücken-Donoren
0
Wasserstoffbrücken-Akzeptoren
8
Kovalente Einheiten
5
Definierte Stereozentren
0

Auch bekannt als

7758-87-4SynthosCalcium orthophosphatePhosphoric acid, calcium salt (2:3)Tricalcium orthophosphateCalcigenol simpleTertiary calcium phosphateBonarka
16 weitere gemeldete Namen
Calcium phosphate, tribasicCalcium tertiary phosphateCalcium phosphate (3:2)Natural whitlockiteFEMA No. 3081Calcium phosphate (Ca3(PO4)2)Calcium orthophosphate, tri-(tert)Tricalcium phosphate (Ca3(PO4)2)K4C08XP666Phosphoric acid calcium(2+) salt (2:3)INS NO.341(III)INS-341(III)E-341(III)BONE POWDER, PURIFIEDcalcium phosphate, tricalcium saltRefChem:6401
Kennungen in externen Datenbanken

Belege aus weiteren wissenschaftlichen Datenbanken

NIH PubChem PUG-View
Exakter Kennungstreffer24456

Attributed physical-property, hazard, environmental and use annotations.

  • First Aid: INHALATION: move to clean air; see physician in case of persistent coughing, expectoration, chest pain, or shortness of breath.; INGESTION: get medical attention quickly; induce vomiting by giving large amounts of water or warm salty water, or by tickling back of patient's throat; continue until vomitus is clear; follow with milk, eggs, or olive oil to soothe stomach.; EYES: immediately flush with large quantities of running water for at least 15 min., holding eyelids apart to insure thorough flushing of eyes and lids; do not attempt to neutralize with chemical agents; get medical attention quickly; if physician is (USCG, 1999) Quelle: CAMEO Chemicals
  • Note: This chemical does not meet GHS hazard criteria for 95.7% (529 of 553) of all reports. Quelle: European Chemicals Agency (ECHA)
  • GHS Hazard Statements: Not Classified; Reported as not meeting GHS hazard criteria by 529 of 553 companies (only 4.3% companies provided GHS information). For more detailed information, please visit ECHA C&L website. Quelle: European Chemicals Agency (ECHA)
  • ECHA C&L Notifications Summary: Aggregated GHS information provided per 553 reports by companies from 6 notifications to the ECHA C&L Inventory.; Reported as not meeting GHS hazard criteria per 529 of 553 reports by companies.; There are 4 notifications provided by 24 of 553 reports by companies with hazard statement code(s).; Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website. Quelle: European Chemicals Agency (ECHA)
  • Note: This chemical does not meet GHS hazard criteria for 75% (27 of 36) of all reports. Quelle: European Chemicals Agency (ECHA)
  • Signal: Danger Quelle: European Chemicals Agency (ECHA)
  • GHS Hazard Statements: H318 (25%): Causes serious eye damage [Danger Serious eye damage/eye irritation] Quelle: European Chemicals Agency (ECHA)
  • Precautionary Statement Codes: P264+P265, P280, P305+P354+P338, and P317 (click each P-code to see the statement) Quelle: European Chemicals Agency (ECHA)
  • ECHA C&L Notifications Summary: Aggregated GHS information provided per 36 reports by companies from 2 notifications to the ECHA C&L Inventory.; Reported as not meeting GHS hazard criteria per 27 of 36 reports by companies.; There is 1 notification provided by 9 of 36 reports by companies with hazard statement code(s).; Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website. Quelle: European Chemicals Agency (ECHA)
  • Cosmetic Ingredient Review Conclusion: The CIR Expert Panel concluded that the following 31 ingredients are safe in the present practices of use and concentration in cosmetics as described in this safety assessment, when formulated to be non-irritating...Calcium Phosphate... Quelle: Cosmetic Ingredient Review (CIR)
  • Cosmetic Ingredient Review Finding(s): Safe for use in cosmetics, with qualifications Quelle: Cosmetic Ingredient Review (CIR)
  • Cosmetic Ingredient Review Conclusion: The CIR Expert Panel concluded that the following 31 ingredients are safe in the present practices of use and concentration in cosmetics as described in this safety assessment, when formulated to be non-irritating...Tricalcium Phosphate... Quelle: Cosmetic Ingredient Review (CIR)
  • Toxicity Summary: IDENTIFICATION AND USE: White amorphous, or crystaline powder. It is odorless and tasteless. It is practically insoluble in alcohol, and acetic acid, and soluble in dilute hydrochloric acid, and nitric acid. Slightly soluble in water. It is used in the manufacture of fertilizers, phosphate compounds, manufacture of milk glass, polishing and dental powders, porcelains, pottery, enameling; clarifying sugar syrups; in animal feeds; as noncaking agent; in textile industry. It is used as a stabilizer in plastics; in meat tenderizers; in food as a buffer and used in medical applications as a calcium replenisher. It veterinary medicine it is used as a dietary supplement and an antacid. It is used in the manufacture of luminescent materials. HUMAN EXPOSURE AND TOXICITY: Tricalcium phosphate is not irritating and toxic doses by ingestion would have to be more than 2 g/kg. Skin sensitization is unusual. Aspiration or inhalation could cause chemical pneumonitis. Implantation of material will cause foreign body reaction. Tricalcium phosphate is contraindicated in treatment of hypocalcemia with hyperphosphatemia which may occur in hypoparathyroidism and renal failure. ANIMAL STUDIES: Tricalcium Quelle: Hazardous Substances Data Bank (HSDB)

Zugeordnet durch: Existing checksum-valid CAS to unique PubChem CID match. Abgerufen: 2026-08-31. Quelleneintrag öffnen

Wissenschaftliche Klassifizierungen und Gefahrenannotationen liefern Kontext und ersetzen nicht die oben gezeigte marktspezifische regulatorische Entscheidung.

Weitere Quellenabdeckung und Trefferstatus
QuelleErgebnisGeprüft
EMBL-EBI ChEBIKein exakter Eintrag2026-08-31
NIH PubChem PUG-ViewExakter Treffer2026-08-31

Ein erfasster Nicht-Treffer ist ein nützlicher Beleg dafür, dass die Quelle geprüft wurde; er ist keine Behauptung, dass der Stoff anderswo nicht existiert.

Am 2026-08-31 von NIH PubChem durch prüfsummengültigen CAS-Abgleich abgerufen. Chemische Eigenschaften ersetzen nicht die regulatorische Entscheidung auf dieser Seite.

Wie CAS 10103-46-5 auf dieser Website verwendet wird

CAS 10103-46-5 ist die Kennung des Chemical Abstracts Service, mit der diese Seite einem bestimmten Stoff zugeordnet wird. Im aktuellen Datenbestand haben 0 EU-Anhangseinträge diese Kennung; so können Sie gegenprüfen, ob derselbe Stoff in einem oder in mehreren regulatorischen Zusammenhängen auftaucht.

Nutzen Sie diese Seite, wenn eine Lieferantenspezifikation, ein Sicherheitsdatenblatt oder ein Rohstoffdossier CAS 10103-46-5 nennt und Sie alle verknüpften Einträge der Anhänge II–VI an einem Ort sehen möchten. Die Eintragskarten oben sind der schnellste Weg zu Konzentrationsgrenzen, Warnhinweisen, Anhangszuordnung und Produktartbedingungen.